Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research & Academic Institutes), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) Market Trends and Forecast to 2027
Some of the major factors contributing to the growth of the market are:
• Increasing launching of new and advance iodinated contrast media
• Improving healthcare infrastructure
Market Players:
The key market players for iodinated contrast media in interventional X-ray market are listed below:
• Bayer AG
• Iso-Tex Diagnostics, Inc.
• Bracco Diagnostic Inc.
• Novalek Pharmaceuticals Pvt. Ltd.
• iMAX
• Taejoon Pharm
• Unijules Life Sciences Ltd
• General Electric
• Guerbet LLC
• J.B.Chemicals & Pharmaceuticals Ltd
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 APPLICATION GRID
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTION
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS
3.1.2 RISING AGING POPULATION
3.1.3 INCREASING NUMBER OF CHRONIC DISEASES
3.1.4 INCREASING RESEARCH ACTIVITIES FOR CONTRAST AGENTS
3.2 RESTRAINTS
3.2.1 HIGH COST OF CONTRAST MEDIA
3.2.2 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
3.3 OPPORTUNITIES
3.3.1 GROWING HEALTHCARE INFRASTRUCTURE
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.3.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
3.3.4 UPCOMING GENERIC CONTRAST MEDIA AGENTS
3.4 CHALLENGES
3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT
3.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION
6.1 OVERVIEW
6.2 INTRAVENOUS
6.3 ORAL
6.4 RECTAL
6.5 OTHERS
7 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL
7.3 SPECIALTY CLINICS
7.3.1 IMAGING CENTERS
7.3.2 PRIVATE PRACTICES
7.4 DIAGNOSTIC CENTERS
7.5 AMBULATORY SURGICAL CENTERS
7.6 RESEARCH & ACADEMIC INSTITUTES
8 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION
8.1 OVERVIEW
8.2 CARDIOLOGY
8.2.1 PERCUTANEOUS CORONARY DISEASE
8.2.2 STRUCTURAL HEART DISEASE
8.2.3 CONGENITAL HEART DISEASE
8.2.4 ELECTROPHYSIOLOGY
8.3 NEUROLOGY
8.4 GENERAL SURGERY
8.5 ONCOLOGY
8.6 UROLOGY
9 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE
9.1 OVERVIEW
9.2 NON-IONIC
9.3 IONIC
10 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY
10.1 ASIA-PACIFIC
10.1.1 CHINA
10.1.2 JAPAN
10.1.3 SOUTH KOREA
10.1.4 INDIA
10.1.5 AUSTRALIA
10.1.6 SINGAPORE
10.1.7 THAILAND
10.1.8 MALAYSIA
10.1.9 INDONESIA
10.1.10 PHILIPPINES
10.1.11 REST OF ASIA-PACIFIC
11 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILES
12.1 BRACCO DIAGNOSTIC INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 COMPANY SHARE ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 RECENT DEVELOPMENT
12.2 GENERAL ELECTRIC
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 GUERBET
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 BAYER AG
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT DEVELOPMENT
12.5 IMAX
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENT
12.6 ISO-TEX DIAGNOSTICS, INC.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 J.B.CHEMICALS AND PHARMACEUTICALS LTD.
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 NOVALEK PHARMACEUTICALS PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 TAEJOON PHARM
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.10 UNIJULES LIFE SCIENCES LTD.
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
UU
TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS
TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS
TABLE 3 COST OF CONTRAST MEDIA
TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS
TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT
TABLE 6 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 7 ASIA- PACIFIC INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 8 ASIA- PACIFIC ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 9 ASIA- PACIFIC RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 10 ASIA- PACIFIC OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 12 ASIA- PACIFIC HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 ASIA- PACIFIC SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 14 ASIA- PACIFIC SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 15 ASIA- PACIFIC DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 16 ASIA- PACIFIC AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 17 ASIA- PACIFIC RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 19 ASIA- PACIFIC CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 ASIA- PACIFIC CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 21 ASIA- PACIFIC NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 ASIA- PACIFIC GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 ASIA- PACIFIC ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 24 ASIA- PACIFIC UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 26 ASIA- PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)
TABLE 27 ASIA- PACIFIC NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 ASIA- PACIFIC IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 31 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 32 ASIA-PACIFIC CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 33 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 34 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 35 ASIA-PACIFIC SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 36 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 37 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 38 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 39 CHINA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 40 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 41 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 42 CHINA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 43 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 44 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 45 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 46 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 47 JAPAN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 48 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 49 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 50 JAPAN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 51 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 52 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 53 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 54 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 55 SOUTH KOREA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 56 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 57 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 58 SOUTH KOREA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 59 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 60 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 61 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 62 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 63 INDIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 64 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 65 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 66 INDIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 67 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 68 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 69 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 70 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 71 AUSTRALIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 72 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 73 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 74 AUSTRALIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 75 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 76 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 77 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 78 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 79 SINGAPORE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 80 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 81 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 82 SINGAPORE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 83 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 84 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 85 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 86 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 87 THAILAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 88 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 89 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 90 THAILAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 91 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 92 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 93 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 94 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 95 MALAYSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 96 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 97 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 98 MALAYSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 99 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 100 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 101 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 102 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 103 INDONESIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 104 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 105 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 106 INDONESIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 107 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 108 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 109 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 110 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 111 PHILIPPINES CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 112 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
TABLE 113 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 114 PHILIPPINES SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 115 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
TABLE 116 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
TABLE 117 REST OF ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...